Esko Aho

 Esko Aho is Executive Chairman of the Board of the East Office of Finnish Industries, a non-profit company of 25 leading Finnish corporations. In addition, he is Chairman of the Board of Cinia Oy and Adven Group. In May 2016, he was elected to the Supervisory Board of Sberbank, Russia´s biggest bank.

Mr. Aho was a Member of the Finnish Parliament for 20 years, from 1983 to 2003. He chaired the Centre Party from 1990 to 2002 and was elected Prime Minister in 1991 at the age of 36, making him the youngest PM in Finland’s history. Under his leadership, Finland joined the European Union. 

After his political career, Mr. Aho served as President of the Finnish Innovation Fund Sitra and then moved on to Nokia Corporation as Executive Vice President of Corporate Relations and Responsibility. Up to the present he has been a Consultative Partner at Nokia. 

Currently, Mr. Aho serves as elected member of the Executive Board at the International Chamber of Commerce. He is an invited member of Club de Madrid, an independent organization of former heads of state and government dedicated to strengthening democracy. 

Throughout his career, Mr. Aho has been active in the world of academia. He has been a Resident Fellow and later Senior Fellow at Harvard University. He is a visiting lecturer at Beijing University and a member of the Industrial Advisory Board at the Russian Presidential Academy of National Economy and Public Administration (RANEPA). He is Executive in Residence at Aalto University, where he works at the Department of Management Studies at the School of Business. He is a visiting lecturer at PSIA, Paris School of International Affairs. He also is a member of the International Advisory Board, NTU Institute of Science and Technology for Humanity, Nanyang Technologia University, Singapore. Mr. Aho holds honorary doctorate degrees from the University of Vaasa, Finland, and the University of Alberta, Canada. 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.